We also investigated the mechanistic role of BAs in NASH in which specific BAs strongly bound to colonic FXR or TGR5 and sustained activation of downstream liver FGF15 and intestinal NF-κB p65, leading to significantly improved hepatic BA homeostasis, lipid metabolism, and metabolic inflammation. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.